Peretz T - Search Results

1

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T. Abeliovich D, et al. Among authors: peretz t. Am J Hum Genet. 1997 Mar;60(3):505-14. Am J Hum Genet. 1997. PMID: 9042909 Free PMC article.

2

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC. Struewing JP, et al. Among authors: peretz t. Nat Genet. 1995 Oct;11(2):198-200. doi: 10.1038/ng1095-198. Nat Genet. 1995. PMID: 7550349

3

Ovarian stimulation and breast cancer: is there a link?

Brzezinski A, Peretz T, Mor-Yosef S, Schenker JG. Brzezinski A, et al. Among authors: peretz t. Gynecol Oncol. 1994 Mar;52(3):292-5. doi: 10.1006/gyno.1994.1051. Gynecol Oncol. 1994. PMID: 8157185

4

Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer.

Shushan A, Peretz T, Uziely B, Lewin A, Mor-Yosef S. Shushan A, et al. Among authors: peretz t. Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):141-4. doi: 10.1016/s0002-9378(96)70386-1. Am J Obstet Gynecol. 1996. PMID: 8571997

5

[Genetic counseling for families at high cancer risk].

Sagi M, Heching N, Kadouri L, Abeliovich D, Zlotogora J, Bach G, Peretz T. Sagi M, et al. Among authors: peretz t. Harefuah. 1996 Apr 1;130(7):441-6, 504. Harefuah. 1996. PMID: 8707209 Hebrew.

6

Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.

Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA. Ben-Yehuda D, et al. Among authors: peretz t. Blood. 1996 Dec 1;88(11):4296-303. Blood. 1996. PMID: 8943866 Free article.

7

[Inherited breast cancer].

Kaduri L, Heshing N, Abeliovich D, Peretz T. Kaduri L, et al. Among authors: peretz t. Harefuah. 1996 Nov 15;131(10):418-21. Harefuah. 1996. PMID: 8981821 Review. Hebrew. No abstract available.

8

BRCA1 mutations in women with ovarian cancer.

Shushan A, Abeliovich D, Peretz T, Weinberg N, Paltiel O. Shushan A, et al. Among authors: peretz t. JAMA. 1997 Mar 26;277(12):963. JAMA. 1997. PMID: 9091664 No abstract available.

9

Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?

Nisman B, Lafair J, Heching N, Lyass O, Baras M, Peretz T, Barak V. Nisman B, et al. Among authors: peretz t. Cancer. 1998 May 15;82(10):1850-9. doi: 10.1002/(sici)1097-0142(19980515)82:10<1850::aid-cncr6>3.0.co;2-r. Cancer. 1998. PMID: 9587116 Clinical Trial.

10

The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction.

Lerer I, Wang T, Peretz T, Sagi M, Kaduri L, Orr-Urtreger A, Stadler J, Gutman H, Abeliovich D. Lerer I, et al. Among authors: peretz t. Am J Hum Genet. 1998 Jul;63(1):272-4. doi: 10.1086/301924. Am J Hum Genet. 1998. PMID: 9634522 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

324 results

Search Page